{"transactions":[{"id":4633008,"issuer":{"id":8065,"kind":"organization","name":"Evogene Ltd."},"owners":[{"id":23833,"kind":"person","name":"RECANATI LEON","position":1,"cik":"0000919590","reported_name":"RECANATI LEON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-09-30T08:13:18.000Z","date":"2026-09-04","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price of the options to purchase Ordinary Shares of the Issuer (the \"Options\") reported in this row is New Israeli Shekels (\"NIS\") 1.75 per share, which is equivalent to $0.58 per share based on the representative exchange rate of NIS 3.0050 per U.S. dollar published by the Bank of Israel on September 4, 2026, the grant date."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 2,500 Options. The Options were granted pursuant to, and are subject to the terms of, the Issuer's 2021 Share Incentive Plan,"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Options vest and become exercisable on a quarterly basis (25% per quarter), commencing on September 4, 2026, such that the Options will be fully vested on September 4, 2027, the one-year anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":0.58,"expiration_date":"2036-09-04","underlying":"Ordinary Shares","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001178913-26-004664","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/919590/000117891326004664/ownership.xml","form_type":"4"}},{"id":4635360,"issuer":{"id":8065,"kind":"organization","name":"Evogene Ltd."},"owners":[{"id":58123,"kind":"person","name":"Nimrodi Nir","position":1,"cik":"0001602806","reported_name":"Nimrodi Nir","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-09-30T08:09:19.000Z","date":"2026-09-04","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options to purchase Ordinary Shares of the Issuer (the \"Options\") is New Israeli Shekels (\"NIS\") 1.75 per share, which is equivalent to $0.58 per share based on the representative exchange rate of NIS 3.0050 per U.S. dollar published by the Bank of Israel on September 4, 2026, the grant date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 10,000 Options. The Options were granted pursuant to, and are subject to the terms of, the Issuer's 2021 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Options vest and become exercisable on a quarterly basis (25% per quarter) commencing on the grant date of September 4, 2026, such that they will be fully vested by September 4, 2027, the one-year anniversary of the grant date."}],"balance_after":10000,"derivative":{"exercise_price":0.58,"expiration_date":"2036-09-04","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001178913-26-004662","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1574565/000117891326004662/ownership.xml","form_type":"4"}},{"id":4635358,"issuer":{"id":8065,"kind":"organization","name":"Evogene Ltd."},"owners":[{"id":58121,"kind":"person","name":"Percy Adrian John","position":1,"cik":"0001980816","reported_name":"Percy Adrian John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-09-30T08:07:28.000Z","date":"2026-09-04","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options to purchase Ordinary Shares of the Issuer (the \"Options\") is New Israeli Shekels (\"NIS\") 1.75 per share, which is equivalent to $0.58 per share based on the representative exchange rate of NIS 3.0050 per U.S. dollar published by the Bank of Israel on September 4, 2026, the grant date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 2,500 Options under the Issuer's 2021 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Options vest and become exercisable on a quarterly basis (25% per quarter) commencing on the grant date of September 4, 2026, such that they will be fully vested by September 4, 2027, the one-year anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":0.58,"expiration_date":"2036-09-04","underlying":"Ordinary Shares","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001178913-26-004660","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1574565/000117891326004660/ownership.xml","form_type":"4"}},{"id":4635359,"issuer":{"id":8065,"kind":"organization","name":"Evogene Ltd."},"owners":[{"id":41463,"kind":"person","name":"Falk Dan Michael","position":1,"cik":"0001966097","reported_name":"Falk Dan Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-09-30T08:05:42.000Z","date":"2026-09-04","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options to purchase Ordinary Shares of the Issuer (the \"Options\") is New Israeli Shekels (\"NIS\") 1.75 per share, which is equivalent to $0.58 per share based on the representative exchange rate of NIS 3.0050 per U.S. dollar published by the Bank of Israel on September 4, 2026, the grant date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 2,500 Options under the Issuer's 2021 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Options vest and become exercisable on a quarterly basis (25% per quarter) commencing on the grant date of September 4, 2026, such that they will be fully vested by September 4, 2027, the one-year anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":0.58,"expiration_date":"2036-09-04","underlying":"Ordinary Shares","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001178913-26-004658","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1574565/000117891326004658/ownership.xml","form_type":"4"}},{"id":674655,"issuer":{"id":8065,"kind":"organization","name":"Evogene Ltd."},"owners":[{"id":19399,"kind":"person","name":"Tarcic Gabi","position":1,"cik":"0002085020","reported_name":"Tarcic Gabi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Ordinary Shares","published_at":"2026-08-26T20:00:55.000Z","date":"2026-06-04","kind":"purchase","planned":false,"acquired":true,"shares":1129,"price":0.6,"value":677.4,"ownership":{"direct":true},"balance_after":1129,"source":{"system":"sec-edgar","filing":"0001178913-26-004259","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1574565/000117891326004259/ownership.xml","form_type":"4"}},{"id":688395,"issuer":{"id":8065,"kind":"organization","name":"Evogene Ltd."},"owners":[{"id":23833,"kind":"person","name":"RECANATI LEON","position":1,"cik":"0000919590","reported_name":"RECANATI LEON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-13T11:00:09.000Z","date":"2026-08-11","kind":"purchase","planned":false,"acquired":true,"shares":460000,"price":0.635,"value":292100.0,"ownership":{"direct":true},"balance_after":1343886,"source":{"system":"sec-edgar","filing":"0001178913-26-004095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/919590/000117891326004095/ownership.xml","form_type":"4"}},{"id":696269,"issuer":{"id":8065,"kind":"organization","name":"Evogene Ltd."},"owners":[{"id":23833,"kind":"person","name":"RECANATI LEON","position":1,"cik":"0000919590","reported_name":"RECANATI LEON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-05T20:07:11.000Z","date":"2026-08-04","kind":"purchase","planned":false,"acquired":true,"shares":800000,"price":0.5,"value":400000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 of this row is a weighted average price. These shares were purchased in multiple transactions on August 4, 2026 within a range of prices per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":883886,"source":{"system":"sec-edgar","filing":"0001178913-26-003859","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/919590/000117891326003859/ownership.xml","form_type":"4"}}]}